vs
PubMatic, Inc.（PUBM）与RIGEL PHARMACEUTICALS INC（RIGL）财务数据对比。点击上方公司名可切换其他公司
PubMatic, Inc.的季度营收约是RIGEL PHARMACEUTICALS INC的1.1倍（$80.0M vs $69.8M），RIGEL PHARMACEUTICALS INC同比增速更快（21.2% vs -6.4%），过去两年RIGEL PHARMACEUTICALS INC的营收复合增速更高（53.7% vs 9.5%）
PubMatic是一家面向数字出版与广告行业的科技企业，核心开发供应端实时程序化广告交易系统，依托自动化技术连接网站、视频、移动端应用的出版商与广告买家，同时支持用户选择不共享个人信息，目前在全球多国设有办公网点。
Rigel制药是一家临床阶段生物技术企业，专注于研发及商业化针对自身免疫性疾病、炎症性疾病与血液疾病的靶向小分子疗法，核心市场位于美国，旗下已获批产品可治疗成人免疫性血小板减少症，致力于满足未被覆盖的临床医疗需求。
PUBM vs RIGL — 直观对比
营收规模更大
PUBM
是对方的1.1倍
$69.8M
营收增速更快
RIGL
高出27.6%
-6.4%
两年增速更快
RIGL
近两年复合增速
9.5%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $80.0M | $69.8M |
| 净利润 | — | $268.1M |
| 毛利率 | 68.2% | 91.5% |
| 营业利润率 | 10.6% | 33.2% |
| 净利率 | — | 384.0% |
| 营收同比 | -6.4% | 21.2% |
| 净利润同比 | — | 1769.2% |
| 每股收益（稀释后） | $0.14 | $14.11 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收PUBMRIGL
| Q4 25 | $80.0M | $69.8M | ||
| Q3 25 | $68.0M | $69.5M | ||
| Q2 25 | $71.1M | $101.7M | ||
| Q1 25 | $63.8M | $53.3M | ||
| Q4 24 | $85.5M | $57.6M | ||
| Q3 24 | $71.8M | $55.3M | ||
| Q2 24 | $67.3M | $36.8M | ||
| Q1 24 | $66.7M | $29.5M |
净利润PUBMRIGL
| Q4 25 | — | $268.1M | ||
| Q3 25 | $-6.5M | $27.9M | ||
| Q2 25 | $-5.2M | $59.6M | ||
| Q1 25 | $-9.5M | $11.4M | ||
| Q4 24 | — | $14.3M | ||
| Q3 24 | $-912.0K | $12.4M | ||
| Q2 24 | $2.0M | $-1.0M | ||
| Q1 24 | $-2.5M | $-8.2M |
毛利率PUBMRIGL
| Q4 25 | 68.2% | 91.5% | ||
| Q3 25 | 62.6% | 93.2% | ||
| Q2 25 | 62.6% | 95.6% | ||
| Q1 25 | 59.9% | 91.7% | ||
| Q4 24 | 70.8% | 89.9% | ||
| Q3 24 | 64.5% | 85.5% | ||
| Q2 24 | 62.6% | 92.4% | ||
| Q1 24 | 61.9% | 93.1% |
营业利润率PUBMRIGL
| Q4 25 | 10.6% | 33.2% | ||
| Q3 25 | -12.4% | 40.9% | ||
| Q2 25 | -7.7% | 60.1% | ||
| Q1 25 | -18.6% | 23.9% | ||
| Q4 24 | 17.3% | 28.9% | ||
| Q3 24 | -1.9% | 25.4% | ||
| Q2 24 | -5.9% | 1.2% | ||
| Q1 24 | -8.3% | -23.6% |
净利率PUBMRIGL
| Q4 25 | — | 384.0% | ||
| Q3 25 | -9.5% | 40.2% | ||
| Q2 25 | -7.3% | 58.6% | ||
| Q1 25 | -14.9% | 21.5% | ||
| Q4 24 | — | 24.9% | ||
| Q3 24 | -1.3% | 22.5% | ||
| Q2 24 | 2.9% | -2.8% | ||
| Q1 24 | -3.7% | -27.9% |
每股收益（稀释后）PUBMRIGL
| Q4 25 | $0.14 | $14.11 | ||
| Q3 25 | $-0.14 | $1.46 | ||
| Q2 25 | $-0.11 | $3.28 | ||
| Q1 25 | $-0.20 | $0.63 | ||
| Q4 24 | $0.26 | $0.82 | ||
| Q3 24 | $-0.02 | $0.70 | ||
| Q2 24 | $0.04 | $-0.06 | ||
| Q1 24 | $-0.05 | $-0.47 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $145.5M | $155.0M |
| 总债务越低越好 | — | $52.5M |
| 股东权益账面价值 | $262.6M | $391.5M |
| 总资产 | $680.2M | $513.6M |
| 负债/权益比越低杠杆越低 | — | 0.13× |
8季度趋势，按日历期对齐
现金及短期投资PUBMRIGL
| Q4 25 | $145.5M | $155.0M | ||
| Q3 25 | $136.5M | $137.1M | ||
| Q2 25 | $90.5M | $108.4M | ||
| Q1 25 | $101.8M | $77.1M | ||
| Q4 24 | $100.5M | $77.3M | ||
| Q3 24 | $78.9M | $61.1M | ||
| Q2 24 | $73.5M | $49.1M | ||
| Q1 24 | $80.2M | $49.5M |
总债务PUBMRIGL
| Q4 25 | — | $52.5M | ||
| Q3 25 | — | $60.0M | ||
| Q2 25 | — | $60.0M | ||
| Q1 25 | — | $60.0M | ||
| Q4 24 | — | $60.0M | ||
| Q3 24 | — | $60.0M | ||
| Q2 24 | — | $60.0M | ||
| Q1 24 | — | $60.0M |
股东权益PUBMRIGL
| Q4 25 | $262.6M | $391.5M | ||
| Q3 25 | $245.1M | $117.6M | ||
| Q2 25 | $243.3M | $81.9M | ||
| Q1 25 | $275.6M | $18.6M | ||
| Q4 24 | $277.3M | $3.3M | ||
| Q3 24 | $263.2M | $-14.6M | ||
| Q2 24 | $282.7M | $-29.9M | ||
| Q1 24 | $288.7M | $-31.7M |
总资产PUBMRIGL
| Q4 25 | $680.2M | $513.6M | ||
| Q3 25 | $676.2M | $242.5M | ||
| Q2 25 | $675.2M | $206.7M | ||
| Q1 25 | $668.6M | $176.0M | ||
| Q4 24 | $739.5M | $164.0M | ||
| Q3 24 | $689.1M | $139.4M | ||
| Q2 24 | $673.1M | $128.4M | ||
| Q1 24 | $626.2M | $126.5M |
负债/权益比PUBMRIGL
| Q4 25 | — | 0.13× | ||
| Q3 25 | — | 0.51× | ||
| Q2 25 | — | 0.73× | ||
| Q1 25 | — | 3.23× | ||
| Q4 24 | — | 18.25× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $18.2M | $22.0M |
| 自由现金流经营现金流 - 资本支出 | $11.3M | — |
| 自由现金流率自由现金流/营收 | 14.1% | — |
| 资本支出强度资本支出/营收 | 8.6% | — |
| 现金转化率经营现金流/净利润 | — | 0.08× |
| 过去12个月自由现金流最近4个季度 | $66.7M | — |
8季度趋势，按日历期对齐
经营现金流PUBMRIGL
| Q4 25 | $18.2M | $22.0M | ||
| Q3 25 | $32.4M | $24.0M | ||
| Q2 25 | $14.9M | $30.5M | ||
| Q1 25 | $15.6M | $-893.0K | ||
| Q4 24 | $18.0M | $14.5M | ||
| Q3 24 | $19.1M | $21.7M | ||
| Q2 24 | $11.9M | $302.0K | ||
| Q1 24 | $24.3M | $-5.0M |
自由现金流PUBMRIGL
| Q4 25 | $11.3M | — | ||
| Q3 25 | $27.7M | — | ||
| Q2 25 | $13.6M | — | ||
| Q1 25 | $14.2M | — | ||
| Q4 24 | $13.7M | — | ||
| Q3 24 | $7.4M | — | ||
| Q2 24 | $11.2M | — | ||
| Q1 24 | $23.5M | — |
自由现金流率PUBMRIGL
| Q4 25 | 14.1% | — | ||
| Q3 25 | 40.8% | — | ||
| Q2 25 | 19.1% | — | ||
| Q1 25 | 22.2% | — | ||
| Q4 24 | 16.1% | — | ||
| Q3 24 | 10.3% | — | ||
| Q2 24 | 16.7% | — | ||
| Q1 24 | 35.2% | — |
资本支出强度PUBMRIGL
| Q4 25 | 8.6% | — | ||
| Q3 25 | 6.9% | — | ||
| Q2 25 | 1.9% | — | ||
| Q1 25 | 2.3% | — | ||
| Q4 24 | 5.1% | — | ||
| Q3 24 | 16.3% | — | ||
| Q2 24 | 1.1% | — | ||
| Q1 24 | 1.2% | — |
现金转化率PUBMRIGL
| Q4 25 | — | 0.08× | ||
| Q3 25 | — | 0.86× | ||
| Q2 25 | — | 0.51× | ||
| Q1 25 | — | -0.08× | ||
| Q4 24 | — | 1.01× | ||
| Q3 24 | — | 1.75× | ||
| Q2 24 | 6.06× | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
